By designating just one reference stated drug as being the normal to which all generic variations must be proven for being bioequivalent, FDA hopes to avoid possible substantial versions amongst generic drugs as well as their model name counterpart. Quoted prices are for hard cash-spending consumers and are not legitimate with insurance coverage